Autoimmune hypophysitis: new developments

Handb Clin Neurol. 2014:124:417-22. doi: 10.1016/B978-0-444-59602-4.00029-0.

Abstract

Autoimmune hypophysitis, often referred to as lymphocytic hypophysitis, is defined as an inflammatory condition of the pituitary gland of autoimmune etiology that leads to pituitary dysfunction. However, the pathogenesis of autoimmune hypophysitis is still incompletely defined. Although pathogenic autoantibodies in autoimmune hypophysitis have not yet been reported, it has been suggested that several antibodies may be closely related to pathogenesis. Novel clinical entities that are associated with hypophysitis, such as IgG4-related hypophysitis and anti-PIT-1 antibody syndrome, have recently been reported. The findings demonstrate the heterogeneity of the disease and provide important clues for understanding the pathogenesis and definition of hypophysitis, as well as the significance of antipituitary antibodies. This review focuses on new developments in autoimmune hypophysitis.

Keywords: Autoimmune hypophysitis; IgG4-related hypophysitis; PIT-1; TPIT; anti-PIT-1 antibody syndrome; lymphocytic hypophysitis; pituitary dysfunction.

Publication types

  • Review

MeSH terms

  • Animals
  • Autoantibodies / blood*
  • Autoimmune Hypophysitis / blood*
  • Autoimmune Hypophysitis / diagnosis*
  • Autoimmune Hypophysitis / therapy
  • Humans
  • Pituitary Diseases / blood
  • Pituitary Diseases / diagnosis
  • Pituitary Diseases / therapy
  • Pituitary Gland / metabolism*
  • Pituitary Gland / pathology

Substances

  • Autoantibodies